Nektar Therapeutics
NKTR
NKTR
336 hedge funds and large institutions have $5.91B invested in Nektar Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 124 increasing their positions, 124 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 349 → 336 (-13)
15% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 39
49% less call options, than puts
Call options by funds: $35.1M | Put options by funds: $69.3M
Holders
336
Holding in Top 10
3
Calls
$35.1M
Puts
$69.3M
Top Buyers
| 1 | +$713M | |
| 2 | +$73.6M | |
| 3 | +$31.3M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$28.6M |
| 5 |
BlackRock
New York
|
+$25.1M |
Top Sellers
| 1 | -$59.3M | |
| 2 | -$29.3M | |
| 3 | -$22.5M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$15.9M |
| 5 |
Morgan Stanley
New York
|
-$12.3M |